Sumitomo Dainippon Pharma Enriches Oncology Pipeline with Tolero Acquisition
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 1 (Table of Contents)
Published: 20 Jan-2017
DOI: 10.3833/pdr.v2017.i1.2219 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Sumitomo Dainippon Pharma has entered into an agreement to acquire US biotech, Tolero Pharmaceuticals, for up to US$780 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS